Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue

Gynecologic Oncology

Volumn 65, Issue 2, 1997, Pages 366-369

  Van Besien, Koen ^a   Verschraegen, Claire ^a   Mehra, Rakesh ^a   Giralt, Sergio ^a   Kudelka, Andrzej P ^a   Edwards, Creighton L ^a   Piamsonboom, Surintip ^b   Termrungruanglert, Wichai ^c   Champlin, Richard ^a   Kavanagh, John J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE;

ADULT; ARTICLE; BONE MARROW SUPPRESSION; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CHORIOCARCINOMA; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; PRIORITY JOURNAL; TROPHOBLASTIC DISEASE;

EID: 0031148788     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4677     Document Type: Article

References (30)

1. Frei E III, Canellos G P. Dose: a critical factor in cancer chemotherapy. Am J Med. 69:1980;585-594.
2. Peters W P, Ross M, Vredenburgh J J, Hussein A, Rubin P, Dukelow K, Cavanaugh C, Beauvais R, Kasprzak S. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer. Semin Oncol. 21:1994;25-31.
3. Jagannath S, Vesole D H, Glenn L, Crowley J, Barlogie B. Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. Blood. 80:1992;1666-1672.
4. Shea T C, Mason J R, Storniolo A M, Newton B, Breslin M, Mullen M, Ward D M, Miller L, Christian M, Taetle R. Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy. J Clin Oncol. 10:1992;464-473.
5. Shea T, Graham M, Steagall A, Bernard S, Wiley J, Moore D, Gonzales P, Johnston C, Brecher M, Bentley S, Van Le L, Fowler W. Multiple cycles of high dose taxol plus carboplatin with G-CSF and peripheral blood progenitor cell support. Proc ASCO. 13:1994;150.
6. Hoskins W J, Perez C, Young R C. Gynecologic Tumors. Cancer, Principles and Practice of Oncology. 1993;Lippincott, Philadelphia. p. 1152-.
7. Page R D, Kudelka A, Freedman R S. Gestational Trophoblastic Tumors. Pazdur R. Medical Oncology: A Comprehensive Review. 1996;377 Huntingdon.
8. Newlands F S, Bagshawe K D, Regent R HJ. Results with the EMA/CO regimen in high risk gestational trophoblastic tumors. Br J Obstet Gynecol. 98:1991;550-557.
9. Surwit E A, Childers J M. High-risk metastatic gestational trophoblastic disease. A new dose-intensive multi-agent chemotherapeutic regimen. J Reprod Med. 36:1991;45-48.
10. Azab M, Droz J-P, Theodore C. Cisplatin, vinblastine and bleomycin combination in the treatment of high-risk gestational trophoblastic tumors. Cancer. 64:1989;1829-1832.
11. Hansen L A, Clayton B D. Treatment of gestational trophoblastic tumors. Drug Intell Clin Pharmacol. 18:1984;569-576.
12. Termrungruanglert W, Kudelka A, Piamsomboon S, Verschraegen C F, Edwards C L, Lifshitz S, Mante R, Kavanagh J J. Remission of refractory gestational trophoblastic disease with high-dose paclitaxel. Anti-Cancer Drugs. 7:1996;1-4.
13. Stehlin J S, Natelson E A, Hinz H R, Giovanella B C, de Ipolyi P D, Fehri K M, Trezona T P, Vardeman D M, Harris N J, Marcee A K, Kozielski A J, Ruiz-Razura A. Phase I Clinical Trial and Pharmacokinetics Results with Oral Administration of 20(S. Potmesil M, Pinedo H. Camptothecins: New Anticancer Agents. 1995;59 CRC Press, Boca Raton.
14. Fields K K, Zorsky P E, Hiemenz J W, Kronish L E, Elfenbein G J. Ifosfamide, carboplatin, and etoposide: a new regimen with a broad spectrum of activity. J Clin Oncol. 12:1994;544-552.
15. S, Piamsomboon, W, Termrungruanglert, A, Kudelka, C, F, Verschraegen, C, L, Edwards, K, van Besien, S, Lifschitz, R, Mante, J, J, Kavanagh, 1996, Remission in the Brain of a Refractory Gestational Trophoblastic Disease with Mini-dose Ifosfamide, Carboplatin, Etoposide (mini-ICE): First Report and Review of the Literature.
16. Fields K K, Elfenbein G J, Lazarus H M, Cooper B W, Perkins J B, Creger R J, Ballester O F, Hiemenz J H, Janssen W E, Zorsky P E. Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile. J Clin Oncol. 13:1995;323-332.
17. Lotz J P, Andre T, Donsimoni R, Firmin C, Bouleuc C, Bonnak H, Merad Z, Esteso A, Gerota J, Izrael V. High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults. Cancer. 75:1995;874-885.
18. Meyers J D. Infections in Marrow Transplant Recipients. Mandell G L, Douglas G R, Bennett J E. Principles and Practice of Infectious Diseases. 1990;2291 Churchill Livingstone, New York.
19. Bearman S I, Appelbaum F R, Buckner C D, Petersen F B, Fisher L D, Clift R A, Thomas E D. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol. 6:1988;1562-1568.
20. Norton L, Simon R. Tumor size, sensitivity to therapy, and design of treatment schedules. Cancer Treat Rep. 61:1977;1307-1317.
21. Norton L, Simon R. The Norton-Simon hypothesis revisited. Cancer Treat Rep. 70:1986;163-169.
22. Demicheli R. Growth of testicular neoplasm lung metastases: tumor specific relation between two Gompertzian parameters. Eur J Cancer Clin Oncol. 16:1980;1603-1608.
23. Sullivan P W, Salmon S. Kinetics of tumor growth and regression in IgG multiple myeloma. J Clin Invest. 51:1972;1697-1708.
24. Bezwoda W R, Seymour L, Dansey R D. High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. J Clin Oncol. 13:1995;2843-2849.
25. Kennedy M J. High-dose chemotherapy of breast cancer: is the question answered? J Clin Oncol. 13:1995;2477-2479.
26. K, H, Antman, A, Elias, H, A, Fine, Dose-Intensive Therapy with Autologous Bone Marrow Transplantation in Solid Tumors, S, J, FormanK, G, BlumeE, D, Thomas, 767, Blackwell Scientific, Cambridge, MA.
27. Nichols C R, Tricot G, Williams S D, Van Besien K W, Loehrer P J, Roth B J, Akard L, Hoffman R, Goulet R, Wolff S N, Giannone L, Greer J, Einhorn L H, Jansen J. Dose-intensive chemotherapy in refractory germ cell cancer - a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol. 7:1989;932-939.
28. Vesole D H, Tricot G, Jagannath S, Desikan K R, Siegel D, Bracy D, Miller L, Cheson B, Crowley J, Barlogie B. Autotransplants in multiple myeloma: what have we learned? Blood. 88:1996;838-847.
29. Hryniuk W M, Goodyear M. The calculation of received dose intensity. J Clin Oncol. 8:1990;1935-1937.
30. Frei E III, Freireich E J. The clinical cancer researcher - still an embattled species. J Clin Oncol. 11:1993;1639-1651.